U.S. Markets closed

iRadimed Corp (IRMD) Files 10-K for the Fiscal Year Ended on December 31, 2018

- By insider

iRadimed Corp (IRMD) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. iRadimed Corp develops, manufactures, markets and distributes Magnetic Resonance Imaging compatible products to acute care facilities and outpatient imaging centers, both in the United States and internationally. iRadimed Corp has a market cap of $266.251 million; its shares were traded at around $24.35 with a P/E ratio of 46.79 and P/S ratio of 9.71. iRadimed Corp had annual average EBITDA growth of 5.40% over the past five years.

For the last quarter iRadimed Corp reported a revenue of $8.34 million, compared with the revenue of $6.71 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $30.4 million, an increase of 31.9% from last year. For the last five years iRadimed Corp had an average revenue growth rate of 19.1% a year.

The reported diluted earnings per share was 52 cents for the year, an increase of 1200% from previous year. Over the last five years iRadimed Corp had an average EPS decline of 1.5% a year. The iRadimed Corp had a decent operating margin of 19.72%, compared with the operating margin of 5.57% a year before. The 10-year historical median operating margin of iRadimed Corp is 19.72%. The profitability rank of the company is 8 (out of 10).

At the end of the fiscal year, iRadimed Corp has the cash and cash equivalents of $28.0 million, compared with $18.2 million in the previous year. The company had no long term debt. iRadimed Corp has a financial strength rank of 10 (out of 10).

At the current stock price of $24.35, iRadimed Corp is traded at 36.1% premium to its historical median P/S valuation band of $17.89. The P/S ratio of the stock is 9.71, while the historical median P/S ratio is 7.11. The stock gained 87.31% during the past 12 months.

Directors and Officers Recent Trades:

  • Director Monty K Allen sold 10,000 shares of IRMD stock on 03/05/2019 at the average price of $25.39. The price of the stock has decreased by 4.1% since.
  • VP MANUFACTURING Steven M. Nardi sold 1,418 shares of IRMD stock on 03/04/2019 at the average price of $26.07. The price of the stock has decreased by 6.6% since.

For the complete 20-year historical financial data of IRMD, click here.

This article first appeared on GuruFocus.